Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor

Neuropsychopharmacology

Volumn 33, Issue 2, 2008, Pages 406-417

  Holick, Kerri A ^a   Lee, Daniel C ^a   Hen, René ^a   Dulawa, Stephanie C ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antidepressant; BALB cJ strain; Forced swimming test; Neurogenesis; Novelty induced hypophagia; Serotonin 1A receptor

Indexed keywords

ANTIDEPRESSANT AGENT; BROXURIDINE; DESIPRAMINE; DOUBLECORTIN; FLUOXETINE; HALOPERIDOL; NEUROLEPTIC AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BAGG ALBINO MOUSE; BEHAVIOR; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEEDING BEHAVIOR; GENE DELETION; HIPPOCAMPUS; LONG TERM CARE; MOUSE; MOUSE STRAIN; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; EXPLORATORY BEHAVIOR; FLUOXETINE; HIPPOCAMPUS; KINETICS; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NEURONS; RECEPTOR, SEROTONIN, 5-HT1A; STEM CELLS; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 36949037305     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301399     Document Type: Article

References (63)

1. Alonso R, Griebel G, Pavone G, Stemmelin J, Le Fur G, Soubrie P (2004). Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Mol Psychiatry 9: 278-286, 224.
2. Andreoli V, Caillard V, Deo RS, Rybakowski JK, Versiani M (2002). Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. J Clin Psychopharmacol 22: 393-399.
3. Anisman H, Hayley S, Kelly O, Borowski T, Merali Z (2001). Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci 115: 443-454.
4. Belzung C, Griebel G (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125: 141-149.
5. Blier P (2003). The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol 13: 57-66.
6. Blier P, de Montigny C, Chaput Y (1987). Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7(Suppl 6): 24S-35S.
7. Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988). The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berlin) 95: 298-302.
8. Bouwknecht JA, Paylor R (2002). Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behavorial Brain Res 136: 489-501.
9. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG (2003). Transient expression of doublecortin during adult neurogenesis. J Comparative Neurol 467: 1-10.
10. Caccia S, Cappi M, Fracasso C, Garattini S (1990). Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berlin) 100: 509-514.
11. Caldarone BJ, Karthigeyan K, Harrist A, Hunsberger JG, Wittmack E, King SL et al (2003). Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharmacology (Berlin) 170: 94-101.
12. Castren E (2004). Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4: 58-64.
13. Costa e Silva JA (2004). From restoration of neuroplasticity to the treatment of depression: clinical experience. Eur Neuropsychopharmacol 14(Suppl 5): S511-S521.
14. Cryan JF, Lucki I (2000). Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther 295: 1120-1126.
15. Cryan JF, Page ME, Lucki I (2005). Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berlin) 182: 335-344.
16. De Nayer A, Geerts S, Ruelens L, Schittecatte M, De Bleeker E, Van Eeckhoutte I et al (2002). Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. Int J Neuropsychopharmacol 5: 115-120.
17. Detke MJ, Johnson J, Lucki I (1997). Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5: 107-112.
18. Detke MJ, Wieland S, Lucki I (1995). Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology (Berlin) 119: 47-54.
19. D'Sa C, Duman RS (2002). Antidepressants and neuroplasticity. Bipolar Disord 4: 183-194.
20. Dulawa SC, Hen R (2005). Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test. Neurosci Biobehav Rev 29: 771-783.
21. Dulawa SC, Holick KA, Gundersen B, Hen R (2004). Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29: 1321-1330.
22. Encinas JM, Vaahtokari A, Enikolopov G (2006). Fluoxetine targets early progenitor cells in the adult brain. Proc Nat Acad Sci USA 103: 8233-8238.
23. Fuchs E, Flugge G, Czeh B (2006). Remodeling of neuronal networks by stress. Frontiers Biosci 11: 2746-2758.
24. Hayley S, Borowski T, Merali Z, Anisman H (2001). Central monoamine activity in genetically distinct strains of mice following a psychogenic stressor: effects of predator exposure. Brain Res 892: 293-300.
25. Hensler JG (2002). Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26: 565-573.
26. Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y et al (2005). Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br J Pharmacol 144: 695-702.
27. Huang GJ, Herbert J (2006). Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 59: 619-624.
28. Jacobson LH, Cryan JF (2007). Feeling strained? Influence of genetic background on depression-related behavior in mice: a review. Behav Genet 37: 171-213.
29. Kampf-Sherf O, Zlotogorski Z, Gilboa A, Speedie L, Lereya J, Rosca P et al (2004). Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants. J Affective Disord 82: 453-459.
30. Kelliher P, Kelly JP, Leonard BE, Sanchez C (2003). Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test. Psychoneuroendocrinology 28: 332-347.
31. Kempermann G, Kuhn HG, Gage FH (1997). Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Nat Acad Sci USA 94: 10409-10414.
32. Koran L, Cain J, Dominguez R, Rush A, Theimann S (1996). Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? Am J Psychiatry 153: 1450-1454.
33. Kreiss DS, Lucki I (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274: 866-876.
34. Kusmider M, Faron-Gorecka A, Dziedzicka-Wasylewska M (2006). Delayed effects of antidepressant drugs in rats. Behav Pharmacol 17: 641-649.
35. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995). Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedeberg's Arch Pharmacol 352: 141-148.
36. Lucassen PJ, Muller MB, Holsboer F, Bauer J, Holtrop A, Wouda J et al (2001). Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 158: 453-468.
37. Lucki I, Dalvi A, Mayorga AJ (2001). Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berlin ) 155: 315-322.
38. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110.
39. Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I (2001). Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 298: 1101-1107.
40. Meshi D, Drew MR, Saxe M, Ansorge MS, David D, Santarelli L et al (2006). Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment. Nat Neurosci 9: 729-731.
41. Miller MW, Nowakowski RS (1988). Use of bromodeoxyuridine- immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res 457: 44-52.
42. Moser PC, Sanger DJ (1999). 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. Eur J Pharmacol 372: 127-134.
43. Muller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJ, Holsboer F, Swaab DF (2001). Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 14: 1603-1612.
44. Owens MJ, Knight DL, Nemeroff CB (2001). Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50: 345-350.
45. Page ME, Abercrombie ED (1997). An analysis of the effects of acute and chronic fluoxetine on extracellular norepinephrine in the rat hippocampus during stress. Neuropsychopharmacology 16: 419-425.
46. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979). Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57: 201-210.
47. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M et al (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Nat Acad Sci USA 95: 14476-14481.
48. Redrobe JP, Bourin M (1998). Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology (Berlin) 138: 198-206.
49. Redrobe JP, MacSweeney CP, Bourin M (1996). The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol 318: 213-220.
50. Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A et al (2006). Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11: 514-522.
51. Reneric JP, Bouvard M, Stinus L (2002). In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs. Behav Brain Res 136: 521-532.
52. Robertson HA (1979). Benzodiazepine receptors in 'emotional' and 'non-emotional' mice; comparison of four strains. Eur J Pharmacol 56: 163-166.
53. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
54. Scott BW, Wojtowicz JM, Burnham WM (2000). Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol 165: 231-236.
55. Shanks N, Griffiths J, Zalcman S, Zacharko RM, Anisman H (1990). Mouse strain differences in plasma corticosterone following uncontrollable footshock. Pharmacol, Biochem, and Behav 36: 515-519.
56. Silver L (2005). Mouse Genetics: Concepts and Applications. Oxford University Press: Bar Harbor, ME.
57. Suckow RF, Zhang MF, Cooper TB (1992). Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clin Chem 38: 1756-1761.
58. Tang X, Orchard SM, Sanford LD (2002). Home cage activity and behavioral performance in inbred and hybrid mice. Behav Brain Res 136: 555-569.
59. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z (2006). Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives Gen Psychiatry 63: 1217-1223.
60. Thomas DN, Nutt DJ, Holman RB (1998). Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex. J Psychopharmacol 12: 366-370.
61. van Praag H, Kempermann G, Gage FH (1999). Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 2: 266-270.
62. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH (2002). Functional neurogenesis in the adult hippocampus. Nature 415: 1030-1034.
63. Yu CC, Woods AL, Levison DA (1992). The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 24: 121-131.